Pancreatic carcinoma is an aggressive subtype of cancer with poor prognosis, known for its refractory nature. To address this challenge, we have established a stable nanoplatform that combines chemotherapy with photodynamic therapy (PDT) to achieve better curative efficacy. First, we designed and synthesized a disulfide-bonded paclitaxel (PTX)-based prodrug, which was further mixed with gemcitabine (GEM) and photosensitizer THPP in an optimized ratio. Subsequently, the mixture was added dropwise into amphiphilic polymer DSPE-PEG water solution to form micelles composed of DSPE-PEG nanoparticles (TPG NPs). The TPG NPs were around 135 nm, and showed great ability of DTT stimulated release of PTX and GEM. Moreover, the TPG NPs can be efficiently uptaken by pancreatic cancer PANC-1 cells and effectively kill them, especially when combined with 650 nm laser irradiation. Finally, the TPG NPs have shown enhanced long-term circulation ability and also exhibited efficient anti-tumor activity in combination with 650 nm laser irradiation in a pancreatic cancer mouse model. In summary, the designed TPG NPs possesses great potential for co-delivery of paclitaxel prodrug, GEM and THPP, which enables combined chemo-photodynamic therapy for cancer treatment. In addition, the stimulated release of PTX prodrug and GEM also allows for better targeting of tumor cells and the increased therapeutic effect against cancer cells. Overall, the TPG NPs can serve as a good candidate for pancreatic cancer treatment.
Magnetic nanomaterials have recently emerged, playing an increasingly essential role in life science and biomedicine fields, and they exhibited promising potentials in cancer diagnosis and therapy. Also, their use as contrast agents improved various cancer diagnostic imaging sensitivities and accuracy. Magnetic nanomaterials are also exploited as targeted drug carriers to increase the sensitivity and reduce the side effects of chemotherapeutic drugs. Herein, we reviewed the preparation, characterization, and surface modification of various magnetic nanomaterials and their cancer diagnosis and therapy applications.
Prostate cancer is one of the major malignancies that threaten men’s health all over the world. Due to the lack of specific symptoms and signs in the early stage, as well as the limitations of existing detection methods, it is difficult to achieve early diagnosis for prostate cancer. As short single‐stranded oligonucleotides (DNA or RNA) with specific 3D structure which can be produced using an in vitro selection process termed systematic evolution of ligands by exponential enrichment (SELEX), aptamers can specifically bind to the corresponding targets. They have become a class of novel targeting ligand for accurate diagnosis and effective treatment of cancer. Owing to distinctive physicochemical features, and some other special properties such as easy modifiability, good biocompatibility, being easily coupled with other ligands, nanomaterials are extensively used in biological medical field research. Enlighteningly, the combination of aptamers with nanomaterials, including metal nanoparticles, nanosilica, quantum dots, and carbon nanomaterials, can enhance the ability of nanomaterials to recognize tumor cells, which is beneficial to overcome the shortcomings such as low sensitivity in early detection and lack of specificity of traditional antineoplastic drugs, thus, clinically helpful to improve the early metaphase diagnosis rate, providing a technical guarantee for the “personalized treatment” strategy for prostate cancer. Herein, we mainly review the basic and applied research of aptamer functionalized nanocomposite in prostate cancer diagnosis and treatment, including biosensing, bioimaging, and cancer therapy, hoping to provide new ideas for prostate cancer diagnosis and treatment.
This study aimed to investigate the characteristics of gray matter volume loss in hippocampal subfields and alterations in whole-brain functional connectivity among patients with diabetic retinopathy (DR), and to examine the correlations between these neural changes and neuropsychological scale scores as well as clinical indicators. Structural and functional magnetic resonance imaging (MRI) data, along with neurocognitive assessments, were acquired from 32 patients with diabetic retinopathy (DR) and 38 age- and sex-matched healthy controls using a Siemens 3.0T MRI scanner. Hippocampal subfield volumes were segmented and extracted using the Anatomy toolbox and Restplus (v1.25) within the MATLAB R2022a environment. Subregions demonstrating significant volumetric alterations were identified through subsequent between-group comparisons and defined as regions of interest (ROIs) for seed-based whole-brain functional connectivity (FC) analysis. The relationships between gray matter volume, functional connectivity values, neuropsychological test scores, and clinical indices were investigated using partial correlation analysis. Compared to healthy controls, patients with diabetic retinopathy (DR) exhibited significantly reduced bilateral entorhinal cortex (EC) volumes and increased volume in bilateral dentate gyrus (DG) (P < 0.05, FDR-corrected). Using these volume-altered subregions as regions of interest (ROIs), seed-based functional connectivity (FC) analysis revealed significantly increased FC strength between the left EC and the left caudate nucleus, alongside significantly decreased FC strength between the right DG and the right middle occipital gyrus (GRF correction: voxel-level p < 0.001, cluster-level p < 0.05, two-tailed). Furthermore, partial correlation analyses demonstrated significant positive correlations between the FC strength of the right hippocampal DG subfield and the right middle occipital gyrus, and scores on both the Montreal Cognitive Assessment (MoCA) (r = 0.560, p = 0.001) and the Mini-Mental State Examination (MMSE) (r = 0.541, p = 0.002). Patients with diabetic retinopathy (DR) demonstrate structural alterations in hippocampal subfields and widespread functional dysconnectivity across the brain. Notably, the strength of functional connectivity between the hippocampus and the visual cortex was significantly and positively correlated with cognitive function. This study provides neuroimaging evidence supporting the mechanisms underlying central nervous system complications in DR, suggesting that hippocampal subfield volumes and specific functional connectivity patterns hold potential as neuroimaging biomarkers for early intervention.